ライフサイエンスコーパス: murine leukemia virus

1 than to those of oncoretroviral RTs, such as murine leukemia virus.

2 or with the amphotropic envelope protein of murine leukemia virus.

3 (HIV-1), simian immunodeficiency virus, and murine leukemia virus.

4 Hrs had no effect on the release of Moloney murine leukemia virus.

5 nter in response to infection by the Abelson murine leukemia virus.

6 rted infection of one cell line (DEL) with a murine leukemia virus.

7 of the RNAs packaged by a model retrovirus, murine leukemia virus.

8 dimerization and packaging domain of Moloney murine leukemia virus.

9 ived growth factor (PDGF)-containing Moloney murine leukemia viruses.

10 ion of proviral integration site for Moloney murine leukemia virus 1 kinase (PIM-1).

11 PIM1 (Proviral Integration site for Moloney murine leukemia virus 1) has emerged as a key regulator

12 kinase proviral integration site for Moloney murine leukemia virus-1 (PIM-1), which in turn regulates

13 The Abelson murine leukemia virus (A-MuLV) expresses an alternative

14 Abelson murine leukemia virus (Ab-MLV) arose from a recombinatio

15 Transformation by Abelson murine leukemia virus (Ab-MLV) is a multistep process in

16 l protein tyrosine kinase encoded by Abelson murine leukemia virus (Ab-MLV) transforms pre-B cells.

17 ginal pipeline, can identify integrations of murine leukemia virus, adeno-associated virus, Tol2 tran

18 Previously, we have demonstrated that murine leukemia virus also escapes inhibition by APOBEC3

19 rupted restriction activity against N-tropic murine leukemia virus and equine infectious anemia virus

20 , similar to canonical retroviruses, such as murine leukemia virus and HIV.

21 fective HIV-1 or Vpu(-) retroviruses such as murine leukemia virus and simian immunodeficiency virus.

22 uently than simple gammaretroviruses such as murine leukemia virus and spleen necrosis virus.

23 on site pattern of XMRV with those found for murine leukemia virus and two human retroviruses, human

24 gene delivery by wild-type ecotropic Moloney murine leukemia virus and vesicular stomatitis virus (VS

25 some glycoproteins, such as those encoded by murine leukemia virus and vesicular stomatitis virus, we

26 OBEC3F (A3F), which are potent inhibitors of murine leukemia virus and Vif-deficient human immunodefi

27 ene whose overexpression blocks infection by murine leukemia viruses and human immunodeficiency virus

28 stigate to what extent virions of HERV-Kcon, murine leukemia virus, and HIV-1 have the ability to tra

29 ents derived from three retroviruses (HIV-1, murine leukemia virus, and Mason-Pfizer monkey virus), t

30 ell lines blocked cytokine induction by HIV, murine leukemia virus, and simian immunodeficiency virus

31 The integration pattern of murine leukemia virus appears to be largely driven by re

32 een XMRV and the intensively studied Moloney murine leukemia virus, architectures of the regulatory d

33 tiviruses and distinct from those of Moloney murine leukemia virus, avian sarcoma leukosis virus, and

34 mbined immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based gamma-retrovirus vector expr

35 sduction efficiency by both HIV- and Moloney murine leukemia virus-based retroviral vectors.

36 By employing a murine leukemia virus-based single-cycle infection assay

37 r more than 1 year after transduction with a murine leukemia virus-based vector encoding the T-cell g

38 We have observed a novel phenotype in a murine leukemia virus capsid mutant, which has normal vi

39 us, MoFe2, or with the parent virus, Moloney murine leukemia virus, caused significant reduction in B

40 The retrovirus ts1, a mutant of Moloney murine leukemia virus, causes oxidative stress and progr

41 so suggest that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory seq

42 ollowed by reverse transcription via Moloney murine leukemia virus, degradation of chromosomal DNA wi

43 of sequences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors.

44 se APOBEC3 does not catalyze base changes in murine leukemia virus DNA, it can be recovered from thes

45 are rapidly loaded onto unintegrated Moloney murine leukemia virus DNAs.

46 ed multiple clonal integrations of ecotropic murine leukemia virus (E-MuLV).

47 Murine leukemia viruses encode a unique form of Gag poly

48 rt of this hypothesis, infection of HIV-1 or murine leukemia virus Env (MLV-Env)-pseudotyped HIV-1 pa

49 lays a defect in proteolytic cleavage of the murine leukemia virus Env cytoplasmic tail in pseudotype

50 d with HIV-1, vesicular stomatitis virus, or murine leukemia virus Env glycoproteins.

51 The trimeric Moloney murine leukemia virus Env protein matures by two proteol

52 urface (SU) or transmembrane (TM) protein of murine leukemia virus Env, along with point mutations th

53 The membrane-proximal region of murine leukemia virus envelope (Env) is a critical modul

54 native viral glycoproteins, including Friend murine leukemia virus envelope (F-MLV Env) are actively

55 For murine leukemia virus envelope (MLV Env) glycoprotein, i

56 For murine leukemia virus envelope (MLV Env) glycoprotein, i

57 or-binding sequence of the ecotropic Moloney murine leukemia virus envelope glycoprotein with the pep

58 studied how the protomeric units of Moloney murine leukemia virus envelope protein (Env) are activat

59 udotyped with vesicular stomatitis virus and murine leukemia virus envelopes, indicating that defensi

60 ammaretrovirus glycoproteins, such as Friend murine leukemia virus (F-MLV) Env, but not with the rela

61 ) in the envelope glycoprotein of the Friend murine leukemia virus (F-MLV) ISD has been reported to a

62 ith defined mixtures of the ecotropic Friend murine leukemia virus (F-MuLV) and different polytropic

63 kely the functionally equivalent sequence in murine leukemia virus Gag has been inferred by mutationa

64 velopment of antitumor immunity using Friend murine leukemia virus gag-expressing mouse EL-4 (EL-4 ga

65 main inserted at random positions throughout murine leukemia virus Gag-Pol, then selecting for varian

66 ells are shown to restrict the expression of murine leukemia virus genomes but not retroviral genomes

67 ith the parental wild-type ecotropic Moloney murine leukemia virus glycoprotein through the ecotropic

68 One such provirus, hortulanus endogenous murine leukemia virus (HEMV), found in a single copy in

69 on by retroviruses that are derived from the murine leukemia virus, human immunodeficiency virus type

70 magnetic resonance structure of the Moloney murine leukemia virus IN (M-MLV) C-terminal domain (CTD)

71 estricts N-tropic (N-MLV), but not B-tropic, murine leukemia virus in a manner dependent upon residue

72 fection by several lentiviruses and N-tropic murine leukemia virus in cow cells.

73 hronically infected with the gammaretrovirus murine leukemia virus in which receptor has been downreg

74 wn of SSRP1 reduces HIV-1 infection, but not Murine Leukemia Virus, in human CD4(+) T cells.

75 We infected >2,500 mice with the SL3-3 murine leukemia virus; in 22 resulting tumors, we found

76 crossover rate similar to that of HIV-1 and murine leukemia virus, indicating that the extremely hig

77 In murine leukemia virus-induced myeloid leukemia in mice,

78 mic lymphocytes by a mink cell focus-forming murine leukemia virus induces apoptosis during the prele

79 se, encoded by the v-Abl oncogene of Abelson murine leukemia virus induces transformation of progenit

80 We found a previously unknown murine leukemia virus infection in one cell line.

81 enhanced antiviral activity against N-tropic murine leukemia virus infection.

82 -5-positive (Lgr5(+)) and B lymphoma moloney murine leukemia virus insertion region homolog-1-positiv

83 The B-lymphoma Moloney murine leukemia virus insertion region-1 protein (BMI1)

84 is (Arabidopsis thaliana) B lymphoma Moloney murine leukemia virus insertion region1 homolog (BMI1) P

85 B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a com

86 e the role of Bmi-1 (B-cell-specific Moloney murine leukemia virus integration site 1) as a regulator

87 We generated murine leukemia virus integrations in human HepG2 and K5

88 Injection of the LP-BM5 murine leukemia virus into mice causes murine AIDS, a di

89 profile of raltegravir on the replication of murine leukemia virus is similar to that for HIV, and th

90 Replication of the murine leukemia viruses is strongly suppressed in mouse

91 ession of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3) in can

92 Moloney murine leukemia virus-like particles (M-VLPs) were compl

93 Non-infectious murine leukemia virus-like particles (M-VLPs) were elect

94 transcriptional profile similar to those of murine leukemia virus-like simple retroviruses.

95 mal recessive mutation (Lamc2(jeb)) due to a murine leukemia virus long terminal repeat insertion in

96 LTR) was found to be higher than the Moloney murine leukemia virus LTRs in both LNCaP and WPMY-1 (sim

97 Moloney murine leukemia virus (M-MLV) replication is restricted

98 In the case of the ecotropic Moloney murine leukemia virus (M-MLV), the Nef-like effect is me

99 that gPr80gag facilitates release of Moloney murine leukemia virus (M-MuLV) from cells along an IFN-s

100 erated within the 3' terminus of the Moloney murine leukemia virus (M-MuLV) pol gene encoding the con

101 The matrix protein (MA) of the Moloney murine leukemia virus (M-MuLV) was found to interact wit

102 deficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV), we determined the effect

103 n immunodeficiency virus type 1) and Moloney murine leukemia virus (M-MuLV), we evaluated how individ

104 The Env protein of murine leukemia virus matures by two cleavage events.

105 ock the release of HIV-1, as well as that of murine leukemia virus (MLV) and Ebola virus (EBOV); knoc

106 We demonstrate that murine leukemia virus (MLV) and human immunodeficiency v

107 tion by mouse mammary tumor virus (MMTV) and murine leukemia virus (MLV) and that there are polymorph

108 the pol gene of gammaretroviruses, including murine leukemia virus (MLV) and xenotropic murine leukem

109 Using the murine leukemia virus (MLV) as a model retrovirus, we ha

110 Using Moloney murine leukemia virus (MLV) as a tool, we examined the e

111 The envelope protein (Env) from the CasBrE murine leukemia virus (MLV) can cause acute spongiform n

112 Murine leukemia virus (MLV) can efficiently spread in ti

113 IM proteins previously identified to inhibit murine leukemia virus (MLV) demonstrated an ability to i

114 gamma-Retroviral murine leukemia virus (MLV) DNA integration into the hos

115 tionship between two recent additions to the murine leukemia virus (MLV) ecotropic subgroup: Mus cerv

116 The glycoprotein murine leukemia virus (MLV) Env can readily form pseudot

117 y, we found that the cytoplasmic tail of the murine leukemia virus (MLV) Env could functionally subst

118 The infectivity of HIV-1 pseudotyped with murine leukemia virus (MLV) Env was not affected by Vpu.

119 ty, we generated chimeric constructs between murine leukemia virus (MLV) Gag and HBV Core to determin

120 The p12 protein of murine leukemia virus (MLV) Gag is associated with the p

121 Here, we show that murine leukemia virus (MLV) has a unique means of counte

122 Murine leukemia virus (MLV) has been studied as one of t

123 and Sleeping Beauty (SB) transposons and the murine leukemia virus (MLV) in mouse embryonic stem cell

124 rved peptide sequence from the C terminus of murine leukemia virus (MLV) IN.

125 The roles of cellular proteases in Moloney murine leukemia virus (MLV) infection were investigated

126 We report alterations to the murine leukemia virus (MLV) integrase (IN) protein that

127 n 3 protein under conditions whereby Moloney murine leukemia virus (MLV) integrase failed to do so, s

128 of understanding the molecular mechanisms of murine leukemia virus (MLV) integration into host chroma

129 We found that the preintegration complex of murine leukemia virus (MLV) interacts with the dynein co

130 n A3G but is sensitive to murine A3, whereas murine leukemia virus (MLV) is relatively resistant to m

131 Murine leukemia virus (MLV) p12, encoded within Gag, bin

132 interferon-alpha-responsive manner, captures murine leukemia virus (MLV) particles and mediates their

133 the efficiencies of restriction of HIV-1 and murine leukemia virus (MLV) particles containing various

134 w analyzed the mRNA content of Psi- and Psi+ murine leukemia virus (MLV) particles using both microar

135 infectious anemia virus (EIAV), or N-tropic murine leukemia virus (MLV) postentry and supported late

136 rs to integrate within active genes, whereas murine leukemia virus (MLV) prefers to integrate near tr

137 l antisera, each prepared against a purified murine leukemia virus (MLV) protein.

138 binding site (PBS)-dependent restriction of murine leukemia virus (MLV) replication in embryonic ste

139 Moloney murine leukemia virus (MLV) selectively encapsidates hos

140 ted glycosylated Gag (glycoGag) protein of a murine leukemia virus (MLV) similarly enhance the infect

141 viruses, we engineered a fluorescent Moloney murine leukemia virus (MLV) system consisting of MLV-int

142 TR1.3 is a Friend murine leukemia virus (MLV) that induces selective syncy

143 Infection with murine leukemia virus (MLV) TR1.3 or the related molecul

144 Using a murine leukemia virus (MLV) variant with an unstable cap

145 ertionally mutagenized somatic cells using a murine leukemia virus (MLV) vector.

146 enhancement of the photonic inactivation of Murine Leukemia Virus (MLV) via 805 nm femtosecond pulse

147 ile infection by the gammaretrovirus Moloney murine leukemia virus (MLV) was unaffected.

148 the properties of the Gag protein of Moloney murine leukemia virus (MLV), a gammaretrovirus.

149 also by vectors bearing the envelope of 10A1 murine leukemia virus (MLV), a murine retrovirus that ca

150 For retroviruses such as HIV-1 and murine leukemia virus (MLV), active receptor recruitment

151 well as simian immunodeficiency virus (SIV), murine leukemia virus (MLV), and the retrotransposon Mus

152 Gammaretroviruses, such as murine leukemia virus (MLV), are functionally distinguis

153 oviral vectors, including those derived from murine leukemia virus (MLV), bearing heterologous Env pr

154 and NC domains in gammaretroviruses, such as murine leukemia virus (MLV), is unique.

155 imers in the case of gammaretroviruses, like murine leukemia virus (MLV), led to the underestimation

156 eported to be contaminated with an ecotropic murine leukemia virus (MLV), raising questions about the

157 four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), a

158 For simple retroviruses, such as murine leukemia virus (MLV), the identities of the cellu

159 se, we used a shuttle vector system in which murine leukemia virus (MLV)-based proviral targets prese

160 ng primary human CD4(+) T lymphocytes with a murine leukemia virus (MLV)-based retroviral vector or x

161 ments in the long terminal repeats (LTRs) of murine leukemia virus (MLV)-based vectors and the vector

162 an gene therapy approaches utilize HIV-1- or murine leukemia virus (MLV)-based vectors, which prefere

163 t may be safer than that of standard Moloney murine leukemia virus (MLV)-derived retroviral vectors.

164 n immunodeficiency virus type 1 (HIV-1)- and murine leukemia virus (MLV)-derived viral vectors, respe

165 ing, are a newly appreciated viral target in murine leukemia virus (MLV)-induced neurodegeneration.

166 The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in pros

167 four subsequent reports failed to detect any murine leukemia virus (MLV)-related virus gene sequences

168 virus-related virus (XMRV) as well as other murine leukemia virus (MLV)-related viruses, though not

169 (mA3) and human APOBEC3G (hA3G) upon Moloney murine leukemia virus (MLV).

170 an immunodeficiency virus type 1 (HIV-1) and murine leukemia virus (MLV).

171 unable to support the replication of Moloney murine leukemia virus (MLV).

172 CD4(+) T lymphocytes are natural targets of murine leukemia virus (MLV).

173 -Pfizer monkey virus (M-PMV) but not Moloney murine leukemia virus (MLV).

174 lated to the hypothetical common ancestor of murine leukemia viruses (MLVs) and other gammaretroviral

175 Murine leukemia viruses (MLVs) and related retroelements

176 Certain murine leukemia viruses (MLVs) are capable of inducing f

177 Many murine leukemia viruses (MLVs) are partially resistant t

178 Mink cell focus-forming (MCF) murine leukemia viruses (MLVs) are the etiologic agent o

179 Certain murine leukemia viruses (MLVs) can induce progressive no

180 The generation of cytopathic effects by murine leukemia viruses (MLVs) in different cell types c

181 for repressing the expression of endogenous murine leukemia viruses (MLVs) in mouse liver.

182 Murine leukemia viruses (MLVs), including xenotropic-MLV

183 Members of the gammaretroviruses--such as murine leukemia viruses (MLVs), most notably XMRV [xenot

184 An RNA kissing loop from the Moloney murine leukemia virus (MMLV) exhibits unusual mechanical

185 ay a similar preintegrative role for Moloney murine leukemia virus (MMLV) in addition to HIV-1.

186 he 3' end processing site within the Moloney murine leukemia virus (MMLV) LTR d(TCTTTCATT), a host-gu

187 elity, we measured the error rate of Moloney murine leukemia virus (MMLV) RT in the presence of sever

188 markedly inhibits the replication of Moloney murine leukemia virus (Mo-MLV) and is required for the a

189 A crystallographic study of the Moloney murine leukemia virus (Mo-MLV) RNase H domain was perfor

190 A/DNMT3L complex to newly integrated Moloney murine leukemia virus (Mo-MuLV) proviral DNA.

191 a novel domain in the Gag protein of Moloney murine leukemia virus (MoLV) that is important for the f

192 eas the prototypical gammaretrovirus Moloney murine leukemia virus (MoMLV) favors strong enhancers an

193 Moloney murine leukemia virus (MoMLV) Gag utilizes its late (L)

194 oviral reverse transcriptase (RT) of Moloney murine leukemia virus (MoMLV) is expressed in the form o

195 o examine the role of this domain in Moloney murine leukemia virus (MoMLV) replication, we analyzed 1

196 The Moloney murine leukemia virus (MoMLV) ribonucleoprotein complex

197 ase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibited Esch

198 h show that tetherin does not affect Moloney murine leukemia virus (MoMLV) spread, and only minimally

199 cle ultrastructure highly similar to Moloney murine leukemia virus (MoMLV), another gammaretrovirus.

200 The ts1 mutant of the Moloney murine leukemia virus (MoMuLV) causes neurodegeneration

201 studies with small fragments of the Moloney murine leukemia virus (MoMuLV) genome suggested that sel

202 The ts1 mutant of Moloney murine leukemia virus (MoMuLV) induces a neurodegenerati

203 enic temperature-sensitive mutant of Moloney murine leukemia virus (MoMuLV-ts1), results in motor neu

204 The cytoplasmic tail of the murine leukemia virus (MuLV) envelope (Env) protein is k

205 odies against clade C HIV-1 gp140, gp120, or murine leukemia virus (MuLV) gp70-scaffolded V1/V2 and t

206 The p12 protein of murine leukemia virus (MuLV) group-specific antigen (Gag

207 PVC-211 murine leukemia virus (MuLV) is a neuropathogenic retrov

208 MEL cells derived from Friend murine leukemia virus (MuLV) or ME26 MuLV-infected mice,

209 Moloney murine leukemia virus (MuLV) preferentially captures tRN

210 from scarce, femtomole quantities of Moloney murine leukemia virus (MuLV) RNA inside authentic virion

211 (2+) (~0.25 mM) and is comparable to Moloney murine leukemia virus (MuLV) RT fidelity.

212 We report here a murine leukemia virus (MuLV) that utilizes its glycosyla

213 High expression of murine leukemia virus (MuLV) transcripts was observed in

214 on with mouse mammary tumor virus (MMTV) and murine leukemia virus (MuLV) via an adaptive immune mech

215 besides MMTV, the animals were infected with murine leukemia virus (MuLV), a gammaretrovirus.

216 n the gammaretroviruses, typified by Moloney murine leukemia virus (MuLV), gag and pol are in the sam

217 opic virus 1 (Bxv1), a xenotropic endogenous murine leukemia virus (MuLV), is present in these 2 rece

218 onatal wild-type (WT) or Mll-AF9 mice with a murine leukemia virus (MuLV).

219 set was found to also contain reads from the murine leukemia virus (MuLV).

220 wever, the mechanism of APOBEC inhibition of murine leukemia viruses (MuLVs) does not appear to be G-

221 All gammaretroviruses, including murine leukemia viruses (MuLVs), feline leukemia viruses

222 viruses that generate recombinant polytropic murine leukemia viruses (MuLVs).

223 nfected with mixtures of mouse retroviruses (murine leukemia viruses [MuLVs]) exhibit dramatically al

224 For the restriction of N-tropic murine leukemia virus (N-MLV) and equine infectious anem

225 rs TRIM5alpha(hu) and Fv-1 restrict N-tropic murine leukemia virus (N-MLV) infection at an early post

226 capsid, we had previously selected N-tropic murine leukemia virus (N-MLV) mutants escaping from rhes

227 iction of the TRIM5alpha-sensitive, N-tropic murine leukemia virus (N-MLV) rendered HIV-1 transductio

228 with human TRIM5alpha inhibition of N-tropic murine leukemia virus (N-MLV).

229 The temperature-sensitive form of Abelson murine leukemia virus offers a reversible model to study

230 ells inhibits the replication of HIV but not murine leukemia virus or chikungunya virus.

231 The infectivity of HIV-1 virions bearing murine leukemia virus or vesicular stomatitis virus glyc

232 The provirus integration site for Moloney murine leukemia virus (Pim) 1 kinase is an oncogenic ser

233 Proviral integration site for Moloney murine leukemia virus (Pim) kinases are serine/threonine

234 ecific proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM2 have b

235 f SCID temperature-sensitive form of Abelson murine leukemia virus pre-B cells.

236 ous, replication-competent MMTV or into MMTV/murine leukemia virus pseudotypes had no effect on incor

237 cture of the double hairpin from the Moloney murine leukemia virus ([Psi(CD)](2), 132 nt, 42.8 kDa) u

238 neonatal infection of rats with the PVC-211 murine leukemia virus (PVC-211 MuLV) and its underlying

239 Homology requirements for Moloney murine leukemia virus recombination were addressed in th

240 We investigated the prevalence of xenotropic murine leukemia virus-related virus (XMRV) among 293 par

241 tly, CFS has been associated with xenotropic murine leukemia virus-related virus (XMRV) as well as ot

242 Xenotropic murine leukemia virus-related virus (XMRV) has been foun

243 Although xenotropic murine leukemia virus-related virus (XMRV) has been prev

244 The xenotropic murine leukemia virus-related virus (XMRV) has recently

245 The discovery of xenotropic murine leukemia virus-related virus (XMRV) in human tiss

246 tions regarding the prevalence of xenotropic murine leukemia virus-related virus (XMRV) in patients w

247 ecent study identified DNA from a xenotropic murine leukemia virus-related virus (XMRV) in peripheral

248 Xenotropic murine leukemia virus-related virus (XMRV) infection was

249 We analyzed xenotropic murine leukemia virus-related virus (XMRV) integration s

250 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

251 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

252 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

253 Xenotropic murine leukemia virus-related virus (XMRV) is a gammaret

254 Xenotropic murine leukemia virus-related virus (XMRV) is a new huma

255 Xenotropic murine leukemia virus-related virus (XMRV) is a novel hu

256 Xenotropic murine leukemia virus-related virus (XMRV) was first ide

257 Xenotropic murine leukemia virus-related virus (XMRV) was previousl

258 Xenotropic murine leukemia virus-related virus (XMRV) was recently

259 iency virus type-1 (HIV-1) and of xenotropic murine leukemia virus-related virus (XMRV), a gammaretro

260 Xenotropic murine leukemia virus-related virus (XMRV), a gammaretro

261 (MLV)-based retroviral vector or xenotropic murine leukemia virus-related virus (XMRV), and isolated

262 A novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been ide

263 DNA from a human gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV), in 68 of 101

264 described gammaretrovirus genome, xenotropic murine leukemia virus-related virus (XMRV), in prostate

265 e newly identified retrovirus-the xenotropic murine leukemia virus-related virus (XMRV)-has recently

266 s of authentic genomic RNA of the xenotropic murine leukemia virus-related virus (XMRV).

267 d with the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) can induce rare foc

268 The retrovirus XMRV (xenotropic murine leukemia virus-related virus) has been detected i

269 a gammaretrovirus, termed "XMRV" (xenotropic murine leukemia virus-related virus) in prostate cancers

270 The human retrovirus XMRV (xenotropic murine leukemia virus-related virus) is associated with

271 The human retrovirus XMRV (xenotropic murine leukemia virus-related virus) is associated with

272 ow that a retrovirus called XMRV (xenotropic murine leukemia virus-related virus) was present in the

273 ated the need for Vpu in enhancing HIV-1 and murine leukemia virus release.

274 inding to Fc; the same hot-spots control HIV/murine leukemia virus restriction by TRIM5alpha and medi

275 eonatal infection of these mice with Moloney murine leukemia virus resulted in accelerated tumor onse

276 tor resistance of several commercial Moloney murine leukemia virus reverse transcriptase (MMLV RT) en

277 t to increase the thermostability of Moloney Murine Leukemia Virus reverse transcriptase (MMLV RT), w

278 ted human TRIM5alpha restriction of N-tropic murine leukemia virus reverse transcription.

279 We probed the structure of murine leukemia virus RNA inside virus particles using S

280 These compounds also inhibit Moloney murine leukemia virus RT but not the Klenow fragment of

281 Tan-1 RT enzymatically mimics oncoretroviral murine leukemia virus RT which is characterized by its l

282 Avian myeloblastosis and Moloney murine leukemia virus RTs also bound more stably to RNA-

283 l replication in vivo, I constructed a novel murine leukemia virus strain (FMLV-IL-1beta) that encode

284 , feline leukemia virus subgroup T, and 10A1 murine leukemia virus, this receptor is the human type I

285 Susceptibility of N-tropic murine leukemia virus to 505265-mediated restriction is

286 1 with a replaced envelope gene from Moloney murine leukemia virus to allow HTLV-1 to fuse with murin

287 Using Abelson murine leukemia virus-transformed B cells to model this

288 iption during clonal expansion using Abelson murine leukemia virus-transformed B cells.

289 neurovirulent viruses FrCas(NC) and Moloney murine leukemia virus ts1 indicate that the nascent enve

290 be increased by 3- to 5-fold by placing the murine leukemia virus UAG read-through element upstream

291 icrobe, Stavrou et al. (2015) reveal how the murine leukemia virus uses a sugar-protein shield to pro

292 Replicating Moloney murine leukemia virus viral production was greater in XP

293 TM cleavage in Moloney murine leukemia virus was inhibited by amprenavir, and t

294 ffect was specific to HIV in that release of murine leukemia virus was minimally affected by the pres

295 stingly, our fusion protein did not restrict murine leukemia virus, which does not incorporate Vpr.

296 They both restrict N-tropic murine leukemia virus with similar specificity yet act a

297 r, mouse APOBEC3 protein blocks infection by murine leukemia viruses without catalyzing this base cha

298 variant nonpermissive to XMRV and xenotropic murine leukemia virus (X-MLV) infection, suggesting that

299 iruses (MLVs), most notably XMRV [xenotropic murine leukemia virus (X-MLV)-related virus--have been r

300 g murine leukemia virus (MLV) and xenotropic murine leukemia virus (XMRV), named the CAE (cytoplasmic